Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect

Biochemical Pharmacology

Volumn 83, Issue 6, 2012, Pages 715-722

  Chattopadhyay, Mitali ^a   Kodela, Ravinder ^a   Nath, Niharika ^b   Dastagirzada, Yosef M ^a   Velázquez Martínez, Carlos A ^c   Boring, Daniel ^d   Kashfi, Khosrow ^a  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer prevention; COX independent; Hydrogen sulfide; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; HYDROGEN SULFIDE; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID; SULINDAC;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL KINETICS; CELL PROLIFERATION; DRUG EFFECT; DRUG METABOLISM; HUMAN; HUMAN CELL; HYDROLYSIS; IC 50; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASPIRIN; CELL LINE, TUMOR; CELL PROLIFERATION; GROWTH INHIBITORS; HUMANS; HYDROGEN SULFIDE; IBUPROFEN; NAPROXEN; SULINDAC; THIONES;

EID: 84857056141     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.12.018     Document Type: Article

References (33)

1. L. Li, A. Hsu, and P.K. Moore Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation - a tale of three gases! Pharmacol Ther 123 2009 386 400
2. M.S. Kasparek, D.R. Linden, M.E. Kreis, and M.G. Sarr Gasotransmitters in the gastrointestinal tract Surgery 143 2008 455 459
3. 2S be the third endogenous gaseous transmitter FASEB J 16 2002 1792 1798 (Pubitemid 35340360)
4. P.K. Moore, M. Bhatia, and S. Moochhala Hydrogen sulfide: from the smell of the past to the mediator of the future Trends Pharmacol Sci 24 2003 609 611 (Pubitemid 37494778)
5. K. Abe, and H. Kimura The possible role of hydrogen sulfide as an endogenous neuromodulator J Neurosci 16 1996 1066 1071 (Pubitemid 26140863)
6. J.E. Doeller, T.S. Isbell, G. Benavides, J. Koenitzer, H. Patel, and R.P. Patel Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues Anal Biochem 341 2005 40 51 (Pubitemid 40615718)
7. C. Szabo Hydrogen sulphide and its therapeutic potential Nat Rev Drug Discov 6 2007 917 935 (Pubitemid 350042399)
8. S. Reuter, S.C. Gupta, M.M. Chaturvedi, and B.B. Aggarwal Oxidative stress, inflammation, and cancer: how are they linked Free Radic Biol Med 49 2010 1603 1616
9. A. Sparatore, E. Perrino, V. Tazzari, D. Giustarini, R. Rossi, and G. Rossoni Pharmacological profile of a novel H(2)S-releasing aspirin Free Radic Biol Med 46 2009 586 592
10. L. Li, G. Rossoni, A. Sparatore, L.C. Lee, P. Del Soldato, and P.K. Moore Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative Free Radic Biol Med 42 2007 706 719 (Pubitemid 46205152)
11. R. Baskar, L. Li, and P.K. Moore Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells FASEB J 21 2007 247 255 (Pubitemid 46052563)
12. J.L. Wallace, G. Caliendo, V. Santagada, G. Cirino, and S. Fiorucci Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat Gastroenterology 132 2007 261 271 (Pubitemid 46108763)
13. J.L. Wallace Hydrogen sulfide-releasing anti-inflammatory drugs Trends Pharmacol Sci 28 2007 501 505 (Pubitemid 47488507)
14. J.L. Wallace, G. Caliendo, V. Santagada, and G. Cirino Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346) Br J Pharmacol 159 2010 1236 1246
15. S. Fiorucci, S. Orlandi, A. Mencarelli, G. Caliendo, V. Santagada, and E. Distrutti Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis Br J Pharmacol 150 2007 996 1002 (Pubitemid 46625099)
16. E. Distrutti, L. Sediari, A. Mencarelli, B. Renga, S. Orlandi, and E. Antonelli Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels J Pharmacol Exp Ther 316 2006 325 335 (Pubitemid 41832612)
17. A.J. Marti-Carvajal, I. Sola, D. Lathyris, and G. Salanti Homocysteine lowering interventions for preventing cardiovascular events Cochrane Database Syst Rev 2009 CD006612
18. R. Hanif, A. Pittas, Y. Feng, M.I. Koutsos, L. Qiao, and L. Staiano-Coico Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway Biochem Pharmacol 52 1996 237 245 (Pubitemid 26233752)
19. K. Kashfi, Y. Ryan, L.L. Qiao, J.L. Williams, J. Chen, and P. Del Soldato Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect J Pharmacol Exp Ther 303 2002 1273 1282 (Pubitemid 35424414)
20. L. Qiao, R. Hanif, E. Sphicas, S.J. Shiff, and B. Rigas Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells Biochem Pharmacol 55 1998 53 64 (Pubitemid 28101985)
21. B. Rigas, and S.J. Shiff Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenases, and the cell cycle. Their interactions in colon cancer Adv Exp Med Biol 470 1999 119 126
22. G.M. Borthwick, A.S. Johnson, M. Partington, J. Burn, R. Wilson, and H.M. Arthur Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism FASEB J 20 2006 2009 2016 (Pubitemid 44953901)
23. J. Gao, K. Kashfi, and B. Rigas In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism J Pharmacol Exp Ther 312 2005 989 997 (Pubitemid 40293757)
24. S. Shi, Q.S. Li, H. Li, L. Zhang, M. Xu, and J.L. Cheng Anti-apoptotic action of hydrogen sulfide is associated with early JNK inhibition Cell Biol Int 33 2009 1095 1101
25. L. Rinaldi, G. Gobbi, M. Pambianco, C. Micheloni, P. Mirandola, and M. Vitale Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3 Lab Invest 86 2006 391 397
26. W.J. Cai, M.J. Wang, P.K. Moore, H.M. Jin, T. Yao, and Y.C. Zhu The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation Cardiovasc Res 76 2007 29 40 (Pubitemid 47362041)
27. W.J. Cai, M.J. Wang, L.H. Ju, C. Wang, and Y.C. Zhu Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21 Cell Biol Int 34 2010 565 572
28. G. Yang, X. Sun, and R. Wang Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3 FASEB J 18 2004 1782 1784 (Pubitemid 39561683)
29. G. Yang, K. Cao, L. Wu, and R. Wang Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1 J Biol Chem 279 2004 49199 49205 (Pubitemid 39625803)
30. D.D. Thomas, L.A. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, and S. Donzelli The chemical biology of nitric oxide: implications in cellular signaling Free Radic Biol Med 45 2008 18 31
31. K. Kashfi, S. Borgo, J.L. Williams, J. Chen, J. Gao, and A. Glekas Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo J Pharmacol Exp Ther 312 2005 978 988 (Pubitemid 40293756)
32. N. Nath, R. Vassell, M. Chattopadhyay, M. Kogan, and K. Kashfi Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling Biochem Pharmacol 78 2009 1298 1304
33. D.A. Wink, Y. Vodovotz, J. Laval, F. Laval, M.W. Dewhirst, and J.B. Mitchell The multifaceted roles of nitric oxide in cancer Carcinogenesis 19 1998 711 721 (Pubitemid 28376759)